Pepinemab,Trastuzumab 
roche,vaccinex
[]
new data is in from a phase i study of adoptive t-cell therapy in patients with metastatic her2-positive breast cancer. stop by the poster session today, look for abstract 645 and chat with dr. heather han. #sitc22 